companydata.dkPULMOPHARMA ApS: Financial statements 2017
CVR: 36428023
PULMOPHARMA ApS (CVR 36428023) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -120,467 and a net result of DKK -123,491 compared with DKK 0 the year before. Equity amounted to DKK -126,411.
- Gross Profit
- -120,467 kr.
- Profit/Loss
- -123,491 kr.
- Equity
- -126,411 kr.
- Total Assets
- 29,697 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -120 t. | -123 t. | -126 t. | - |
| 2016 | - | 0 | 0 | -3 t. | - |
Find more companies like PULMOPHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
PULMOPHARMA ApS has published its annual report for 2016. Gross profit came to DKK 0, and the net result was DKK 0.
About PULMOPHARMA ApS
PULMOPHARMA ApS is a Danish company of the type Anpartsselskab based in Ebeltoft, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dan Mønster Nielsen. The company's owners include PETER BANG HOLDING ApS, LARS NYENSTAD ApS and BENDIX-HOLDING ApS. In 2025, the company reported a gross profit of DKK -49,353 and a net result of DKK -49,353 compared with DKK -20,499 the year before. Equity amounted to DKK 11,436,934.